B
1.44
-0.09 (-5.88%)
| Previous Close | 1.53 |
| Open | 1.53 |
| Volume | 1,204,070 |
| Avg. Volume (3M) | 1,615,596 |
| Market Cap | 178,588,800 |
| Price / Earnings (Forward) | 25.51 |
| Price / Sales | 0.570 |
| Price / Book | 2.95 |
| 52 Weeks Range | |
| Earnings Date | 11 Nov 2024 - 15 Nov 2024 |
| Profit Margin | -8.10% |
| Operating Margin (TTM) | -27.30% |
| Diluted EPS (TTM) | -0.390 |
| Quarterly Revenue Growth (YOY) | -19.10% |
| Quarterly Earnings Growth (YOY) | -94.00% |
| Total Debt/Equity (MRQ) | 951.60% |
| Current Ratio (MRQ) | 6.56 |
| Operating Cash Flow (TTM) | -5.51 M |
| Levered Free Cash Flow (TTM) | 29.01 M |
| Return on Assets (TTM) | -5.90% |
| Return on Equity (TTM) | -37.64% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Household & Personal Products (US) | Bullish | Mixed |
| Household & Personal Products (Global) | Bullish | Mixed | |
| Stock | The Beauty Health Company | Bullish | Bearish |
Stockmoo Score
-0.9
| Analyst Consensus | 1.5 |
| Insider Activity | -1.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Average | -0.90 |
|
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets, and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products. |
|
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Investment Style | Small Value |
| % Held by Insiders | 8.66% |
| % Held by Institutions | 86.16% |
| 52 Weeks Range | ||
| Median | 1.75 (21.53%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Canaccord Genuity | 13 Nov 2024 | 1.75 (21.53%) | Hold | 1.85 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| GRUBER DESIREE | - | 1.49 | -14,663 | -21,848 |
| Aggregate Net Quantity | -14,663 | |||
| Aggregate Net Value ($) | -21,848 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 1.49 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| GRUBER DESIREE | Director | 20 Nov 2024 | Sell (-) | 14,663 | 1.49 | 21,848 |
| Date | Type | Details |
|---|---|---|
| 12 Nov 2024 | Announcement | BeautyHealth Reports Third Quarter 2024 Financial Results |
| 08 Nov 2024 | Announcement | BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024 |
| 17 Oct 2024 | Announcement | Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery’s Annual Meeting (ASDS): Hydrafacial enhances the outcomes of non-ablative laser and IPL treatments |
| 15 Oct 2024 | Announcement | Hydrafacial Announces Glow Getter Scholarship Program in Support of Estheticians |
| 15 Oct 2024 | Announcement | Hydrafacial Introduces New Clinically Proven Hydralock HA Booster |
| 15 Oct 2024 | Announcement | The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments |
| 01 Oct 2024 | Announcement | Hydrafacial Launches New Hydralock HA Booster with Clinically Proven Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |